<?xml version="1.0" encoding="UTF-8"?>
<p>Crimean-Congo hemorrhagic fever virus (CCHFV) infection was first defined in Turkey in 2003 from persons who became sick during a 2002 CCHFV outbreak (
 <xref ref-type="bibr" rid="R1">
  <italic>1</italic>
 </xref>,
 <xref ref-type="bibr" rid="R2">
  <italic>2</italic>
 </xref>). During 2002–2007, CCHFV was confirmed serologically, virologically, or by both types of testing, in ≈1,800 persons, mainly in the Tokat and Sivas provinces of Turkey (
 <xref ref-type="fig" rid="F1">Figure 1</xref>) (
 <xref ref-type="bibr" rid="R3">
  <italic>3</italic>
 </xref>). This region was then considered an epicenter for CCHFV epidemics (
 <xref ref-type="bibr" rid="R4">
  <italic>4</italic>
 </xref>). This study determined the seroprevalence of CCHFV in a high-risk population living in that region after 4 epidemic seasons and assessed transmission routes of CCHFV infection.
</p>
